Evidence map›Paper›PMID 35705610›Full record

ArticleScientific reports2022

Burden of maternal and fetal outcomes among pregnant cancer survivors during delivery hospitalizations in the United States.

Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Peter McGranaghan, Sandeep Appunni, Md Ashfaq Ahmed, Zhenwei Zhang, Shelbie Burchfield, Raees Tonse, Emir Veledar and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Muni RubensMiami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.
Venkataraghavan RamamoorthyBaptist Health South Florida, Miami, FL, USA.
Anshul SaxenaBaptist Health South Florida, Miami, FL, USA.
Peter McGranaghanMiami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.
Sandeep AppunniGovernment Medical College, Calicut, Kerala, India.
Md Ashfaq AhmedBaptist Health South Florida, Miami, FL, USA.
Zhenwei ZhangBaptist Health South Florida, Miami, FL, USA.
Shelbie BurchfieldFlorida International University, Miami, FL, USA.
Raees TonseMiami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.
Emir VeledarBaptist Health South Florida, Miami, FL, USA.
Rupesh KotechaMiami Cancer Institute, Baptist Health South Florida, Miami, FL, USA. rupeshk@baptisthealth.net.
Baptist Health South Florida · USBaptist Hospital of Miami · USFlorida International University · USGovernment Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Existing studies on pregnancy-related outcomes among cancer survivors are limited by sample size or specificity of the cancer type. This study estimated the burden of adverse maternal and fetal outcomes among pregnant cancer survivors using a national database. This study was a retrospective analysis of National Inpatient Sample collected during 2010-2014. Multivariate regression models were used to calculate odds ratios for maternal and fetal outcomes. The study included a weighted sample of 64,506 pregnant cancer survivors and 18,687,217 pregnant women without cancer. Pregnant cancer survivors had significantly higher odds for death during delivery hospitalization, compared to pregnant women without cancer (58 versus 5 deaths per 100,000 pregnancies). They also had higher odds of severe maternal morbidity (aOR 2.00 [95% CI 1.66-2.41]), cesarean section (aOR 1.27 [95% CI 1.19-1.37]), labor induction (aOR 1.17 [95% CI 1.07-1.29]), pre-eclampsia (aOR 1.18 [95% CI 1.02-1.36]), preterm labor (aOR 1.55 [95% CI 1.36-1.76]), chorioamnionitis (aOR 1.45 [95% CI 1.15-1.82]), postpartum infection (aOR 1.68 [95% CI 1.21-2.33]), venous thromboembolism (aOR 3.62 [95% CI 2.69-4.88]), and decreased fetal movements (aOR 1.67 [95% CI 1.13-2.46]). This study showed that pregnancy among cancer survivors constitutes a high-risk condition requiring advanced care and collective efforts from multiple subspecialties.

Indexed as

Cancer SurvivorsNeoplasmsCesarean SectionFemaleHospitalizationHumansInfant, NewbornPregnancyPregnancy OutcomeRetrospective StudiesUnited States

Identifiers

PMID35705610
PMCPMC9200828
OpenAlexW4282934818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.